6 independently checked trend briefs about this subject, newest first.
headlinez.news detected 6 source-qualified news clusters connected to Lung Cancer between June 23, 2026 and July 18, 2026. They span 2 newsroom categories and average 5.2 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
Medical reports are highlighting an emerging trend of lung cancer diagnoses in non-smokers under 50, with researchers focusing on potential dietary links.
New research suggests that former smokers who utilize e-cigarettes may encounter elevated risks for lung cancer and mortality.
A new study indicates that lung transplants may improve survival outcomes for select patients diagnosed with Stage 4 lung cancer.
Roche's experimental KRAS inhibitor has outperformed current standard treatments in a head-to-head late-stage clinical trial for lung cancer.
Nature Medicine has retracted a high-profile study concerning the impact of treatment timing on PD-1 lung cancer therapy outcomes.
Pfizer’s experimental lung cancer drug sigvotatug vedotin has failed to meet its primary objective in a late-stage clinical trial.